Primary information |
---|
sequence ID | Seq_2539 |
Peptide sequence | GDEELLRFSN |
CancerPDF_ID | CancerPDF_ID9544, CancerPDF_ID11456, CancerPDF_ID13327, CancerPDF_ID13804, |
PMID | 21533267,26992070,20974924,20974924 |
Protein Name | Protein AMBP,Protein AMBP,Protein AMBP,Protein AMBP |
UniprotKB Entry Name | AMBP_HUMAN,AMBP_HUMAN,AMBP_HUMAN,AMBP_HUMAN |
Fluid | Serum,Serum,Plasma,Plasma |
M/Z | 590.28,1178.5568,1179.565,1179.565 |
Charge | 2,NA,2,2 |
Mass (in Da) | NA,1179.56389,NA,NA |
fdr | NA,NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS,LC-MS |
Peptide Identification technique | LC/MS/MS,LC-MS/MS,LC-MS/MS,LC-MS/MS |
Quantification Technique | Multiple Reaction Monitoring,NA,NA,NA |
Labelled/Label Free | Label Free,Label Free,Label Free,Label Free |
FDR | 1.49,FDR 1 %,NA,NA |
CancerPDF_ID | CancerPDF_ID9544, CancerPDF_ID11456, CancerPDF_ID13327, CancerPDF_ID13804, |
p-Value | NA,NA,NA,NA |
Software | MASCOT,SEQUEST and Maxquant,MASCOT and SEQUEST,MASCOT and SEQUEST |
Length | 10,10,NA,NA |
Cancer Type | Lung adenocarcinoma,Melanoma,"Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia" |
Database | Swissprot Database (57.4),SwissProt Database,Uniprot database,Uniprot database |
Modification | NA,NA,NA,NA |
Number of Patients | 62 lung adenocarcinoma and 30 healthy control,8 cancer samples and 4 healthy samples,NA,NA |
Regulation | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Present in 5 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples.",NA,NA |
Validation | MRM-based validation of 19 candidates,na,NA,NA |
Sensitivity | NA,NA,NA,NA |
Specificity | NA,NA,NA,NA |
Accuracy | NA,NA,NA,NA |
Peptide Atlas | NA |
IEDB | |